Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Viking Therapeutics, Inc. (1VT.F)

22.01
+0.18
+(0.85%)
As of 8:06:17 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
150,921
150,921
100,827
70,355
55,682
Operating Income
-150,921
-150,921
-100,827
-70,355
-55,682
Net Non Operating Interest Income Expense
40,846
40,846
14,932
1,530
685
Other Income Expense
112
112
--
-42
7
Pretax Income
-109,963
-109,963
-85,895
-68,867
-54,990
Net Income Common Stockholders
-109,963
-109,963
-85,895
-68,867
-54,990
Diluted NI Available to Com Stockholders
-109,963
-109,963
-85,895
-68,867
-54,990
Basic EPS
-1.01
--
-0.91
-0.90
-0.71
Diluted EPS
-1.01
--
-0.91
-0.90
-0.71
Basic Average Shares
109,037.12
--
94,347
76,834
77,198
Diluted Average Shares
109,037.12
--
94,347
76,834
77,198
Total Operating Income as Reported
-150,921
-150,921
-100,827
-70,355
-55,682
Total Expenses
150,921
150,921
100,827
70,355
55,682
Net Income from Continuing & Discontinued Operation
-109,963
-109,963
-85,895
-68,867
-54,990
Normalized Income
-110,075
-110,075
-85,895
-68,825
-54,997
Interest Income
40,940
40,940
15,020
1,589
703
Net Interest Income
40,846
40,846
14,932
1,530
685
EBIT
-150,921
-150,921
-100,827
-70,355
-55,682
EBITDA
-150,575
-150,575
-100,535
-70,064
-55,386
Reconciled Depreciation
346
346
292
291
296
Net Income from Continuing Operation Net Minority Interest
-109,963
-109,963
-85,895
-68,867
-54,990
Total Unusual Items Excluding Goodwill
112
112
--
-42
7
Total Unusual Items
112
112
--
-42
7
Normalized EBITDA
-150,687
-150,687
-100,535
-70,022
-55,393
12/31/2021 - 5/11/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PI3.DU Gubra AS
46.80
-2.94%
 
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
 
ASMB Assembly Biosciences, Inc.
10.49
+0.77%
 
SPRB Spruce Biosciences, Inc.
0.1332
+0.23%
 
PTCT PTC Therapeutics, Inc.
50.03
+0.16%
 
LCTX Lineage Cell Therapeutics, Inc.
0.4715
-0.11%
 
VNDA Vanda Pharmaceuticals Inc.
4.3550
+0.58%
 
GRCE Grace Therapeutics, Inc.
2.2983
+0.36%
 
CANF Can-Fite BioPharma Ltd.
1.1800
0.00%
 
TSHA Taysha Gene Therapies, Inc.
1.8800
+3.30%